Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University Hospitals
Headquarters: Cleveland, OH, United States of America
Website: http://www.uhhospitals.org
Year Founded: 1866
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Oct 15, 2024
Management Tracks
Rubin leaving Boundless as CFO, new CSOs for C4, Avacta and Commit
Plus: David Cameron named chair of Oxford-Harrington Rare Disease Centre’s advisory council, and updates from Twist, Boundless, Lucy and more
BioCentury | Sep 14, 2023
Finance
Sept. 14 Quick Takes: Inhaled gene therapy play AlveoGene launches
Plus: Harpoon sinks as AbbVie declines option, and China companies Cure Genetics, Frametact in gene therapy deal
BioCentury | Mar 28, 2022
Management Tracks
Asif Ali to join Protagonist as CFO
Plus new CMO at Avenge Bio, new CEO at
BioCentury | Nov 9, 2021
Management Tracks
Maraganore joins board at Beam
Plus: new CBO, board member at Caribou, Nordic, GT Biopharma and more
BioCentury | Aug 27, 2021
Distillery Therapeutics
Mirtron-based gene therapy to treat RHO-mutant retinitis pigmentosa
BioCentury | Feb 26, 2021
Deals
Feb. 25 Quick Takes: AveXis execs, Deerfield launch Jaguar plus one; Sarepta DMD approval, Apollomics IPO plans and Sirion-Sanofi, an Oxford pair and DeuterOncology
Led by Sean Nolan as executive chairman and Joe Nolan as CEO, the former management team of AveXis partnered with Deerfield Management to launch Jaguar Gene Therapy LLC. Jaguar’s preclinical
BioCentury | Feb 18, 2021
Finance
Advent raises next funds, taps Midwest innovation
Advent Life Sciences’ latest funds include a tie-up with the Harrington Discovery Institute, providing the trans-Atlantic VC with an early look at innovation coming out of the
BioCentury | Jul 20, 2018
Company News
U of Helsinki grants Herantis rights to a non-invasive CDNF approach
BioCentury | Nov 10, 2017
Emerging Company Profile
Computing care
How Tempus is using machine learning to help docs choose cancer treatments
Items per page:
1 - 10 of 93